Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial ; volume:30 ; number:4 ; day:7 ; month:4 ; year:2024 ; pages:1044-1053 ; date:4.2024
Nature medicine ; 30, Heft 4 (7.4.2024), 1044-1053, 4.2024
- Urheber
-
Yarchoan, Mark
Gane, Edward J.
Marron, Thomas U.
Perales-Linares, Renzo
Yan, Jian
Cooch, Neil
Shu, Daniel H.
Fertig, Elana J.
Kagohara, Luciane T.
Bartha, Gabor
Northcott, Josette
Lyle, John
Rochestie, Sarah
Peters, Joann
Connor, Jason T.
Jaffee, Elizabeth M.
Csiki, Ildiko
Weiner, David B.
Perales-Puchalt, Alfredo
Sardesai, Niranjan Y.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-024-02894-y
- URN
-
urn:nbn:de:101:1-2407012125266.122114387434
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yarchoan, Mark
- Gane, Edward J.
- Marron, Thomas U.
- Perales-Linares, Renzo
- Yan, Jian
- Cooch, Neil
- Shu, Daniel H.
- Fertig, Elana J.
- Kagohara, Luciane T.
- Bartha, Gabor
- Northcott, Josette
- Lyle, John
- Rochestie, Sarah
- Peters, Joann
- Connor, Jason T.
- Jaffee, Elizabeth M.
- Csiki, Ildiko
- Weiner, David B.
- Perales-Puchalt, Alfredo
- Sardesai, Niranjan Y.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
Neoantigen vaccine: an emerging tumor immunotherapy
Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer
Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
Neoantigen vaccine: an emerging tumor immunotherapy
Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer
Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
Neoantigen vaccine: an emerging tumor immunotherapy
Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future
TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer
Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention